Forecast of Statin Market to 2018
•Download as PPTX, PDF•
2 likes•1,488 views
The statin drug market is expected to decline significantly through 2018 due to increased generic competition lowering revenues. Global statin revenues are projected to drop from $20.5 billion in 2011 to $12.2 billion in 2018, while US statin revenues will plunge from $8.4 billion in 2011 to $6 billion in 2018 following the loss of patents for major drugs. The highly competitive generic market and limited new therapies will decrease interest in the statin market.
Report
Share
Report
Share
Recommended
دارو و نظام سلامتDr zargari
This document discusses trends in the pharmaceutical industry including global R&D spending, prescription drug sales, and the percentage of sales invested in R&D. It notes that R&D spending grew steadily between 2002 and 2008 but at a slower pace after 2009. The document also outlines several strategic areas that pharmaceutical companies are focusing on, such as plasma fractionation, vaccines, and targeted therapies, to drive future innovation and growth. Finally, it emphasizes the need for the industry to invest in digital technologies and big data analytics to improve R&D productivity and better meet patient needs.
Global Kettle Safety Controls Market: Size, Trends & Forecasts (2017-2021)
The report encompasses a brief regional analysis of Asia Pacific, China, Americas, Europe and ROW (Africa and CIS) market. For details, write to info@daedal-research.com
Forecast of Statin Market to 2018
The statin market is expected to decline significantly through 2018 due to increased generic competition following the loss of patents for major branded statins like Zocor and Lipitor, causing global statin revenues to drop from $20.5 billion in 2011 to an estimated $12.2 billion in 2018, with the U.S. market projected to plunge from $8.4 billion to $6 billion over the same period.
wyeth Citi Investment Research Global Healthcare Conference
This document summarizes Greg Norden's presentation at the 2008 Citi Investment Research Global Healthcare Conference on May 21, 2008. It discusses Wyeth's financial guidance for 2008, performance in the first quarter of 2008, key product growth drivers, focus on driving international growth, pipeline of new products in development, and initiatives to sharpen focus and manage costs through Project Impact. The presentation outlines Wyeth's strategy to position itself for future growth through a diversified business, new product launches, global expansion opportunities, and a proven R&D pipeline.
2012 03 the-global_outlook_for_borates_bob katsiouleris_ind_min_budapest_rtm
Global demand for borates is projected to grow steadily through 2016, driven by agriculture, insulation fiberglass, and glass applications like LCD TVs. Rio Tinto expects global borate demand to increase by around 7% annually until 2016. Key growth regions include Asia, South America, the Middle East, and Africa. To meet rising demand, Rio Tinto is expanding its borate production capacity and developing strategies tailored to regional growth areas and end uses. Ensuring sufficient, sustainable food sources for a growing global population is positioning agriculture as a major driver of increased borate use.
02 Farrell Webcast V1 Kk
This document outlines Coca-Cola's strategic vision and plans for 2020. It projects continued global economic growth, rising incomes, and 1 billion new consumers entering the global economy by 2020. This will drive increased consumption of non-alcoholic ready-to-drink beverages. Coca-Cola aims to more than double its system revenue over this period while expanding margins. Its 2020 business agenda focuses on maximizing cash flow, winning with Coca-Cola brands, accelerating innovation, and optimizing its franchise structure. Coca-Cola also outlines social commitments around sustainability, water stewardship, and promoting active healthy living.
Indonesia Gearing Towards Bio Ethanol Nov08
The document discusses Indonesia's growing bioethanol market and production. It analyzes key factors such as feedstock availability, production processes, market size and projections. Indonesia aims to blend 5% bioethanol into gasoline by 2010 to reduce dependence on fossil fuels and meet energy needs. However, current production from cassava and molasses is insufficient to achieve this target. Challenges include increasing feedstock cultivation and improving smallholder productivity and technology.
Factors to Consider in Project Valuation
This document discusses factors to consider in project valuation. It notes China's growing importance as both a risk and source of returns for commodity companies. Individual factors like resources, costs, and price volatility must be considered. Capital costs regularly exceed estimates. While uncertainty remains, companies can improve valuations through share buybacks or focusing on quality projects rather than assuming commodity demand will always increase.
Recommended
دارو و نظام سلامتDr zargari
This document discusses trends in the pharmaceutical industry including global R&D spending, prescription drug sales, and the percentage of sales invested in R&D. It notes that R&D spending grew steadily between 2002 and 2008 but at a slower pace after 2009. The document also outlines several strategic areas that pharmaceutical companies are focusing on, such as plasma fractionation, vaccines, and targeted therapies, to drive future innovation and growth. Finally, it emphasizes the need for the industry to invest in digital technologies and big data analytics to improve R&D productivity and better meet patient needs.
Global Kettle Safety Controls Market: Size, Trends & Forecasts (2017-2021)
The report encompasses a brief regional analysis of Asia Pacific, China, Americas, Europe and ROW (Africa and CIS) market. For details, write to info@daedal-research.com
Forecast of Statin Market to 2018
The statin market is expected to decline significantly through 2018 due to increased generic competition following the loss of patents for major branded statins like Zocor and Lipitor, causing global statin revenues to drop from $20.5 billion in 2011 to an estimated $12.2 billion in 2018, with the U.S. market projected to plunge from $8.4 billion to $6 billion over the same period.
wyeth Citi Investment Research Global Healthcare Conference
This document summarizes Greg Norden's presentation at the 2008 Citi Investment Research Global Healthcare Conference on May 21, 2008. It discusses Wyeth's financial guidance for 2008, performance in the first quarter of 2008, key product growth drivers, focus on driving international growth, pipeline of new products in development, and initiatives to sharpen focus and manage costs through Project Impact. The presentation outlines Wyeth's strategy to position itself for future growth through a diversified business, new product launches, global expansion opportunities, and a proven R&D pipeline.
2012 03 the-global_outlook_for_borates_bob katsiouleris_ind_min_budapest_rtm
Global demand for borates is projected to grow steadily through 2016, driven by agriculture, insulation fiberglass, and glass applications like LCD TVs. Rio Tinto expects global borate demand to increase by around 7% annually until 2016. Key growth regions include Asia, South America, the Middle East, and Africa. To meet rising demand, Rio Tinto is expanding its borate production capacity and developing strategies tailored to regional growth areas and end uses. Ensuring sufficient, sustainable food sources for a growing global population is positioning agriculture as a major driver of increased borate use.
02 Farrell Webcast V1 Kk
This document outlines Coca-Cola's strategic vision and plans for 2020. It projects continued global economic growth, rising incomes, and 1 billion new consumers entering the global economy by 2020. This will drive increased consumption of non-alcoholic ready-to-drink beverages. Coca-Cola aims to more than double its system revenue over this period while expanding margins. Its 2020 business agenda focuses on maximizing cash flow, winning with Coca-Cola brands, accelerating innovation, and optimizing its franchise structure. Coca-Cola also outlines social commitments around sustainability, water stewardship, and promoting active healthy living.
Indonesia Gearing Towards Bio Ethanol Nov08
The document discusses Indonesia's growing bioethanol market and production. It analyzes key factors such as feedstock availability, production processes, market size and projections. Indonesia aims to blend 5% bioethanol into gasoline by 2010 to reduce dependence on fossil fuels and meet energy needs. However, current production from cassava and molasses is insufficient to achieve this target. Challenges include increasing feedstock cultivation and improving smallholder productivity and technology.
Factors to Consider in Project Valuation
This document discusses factors to consider in project valuation. It notes China's growing importance as both a risk and source of returns for commodity companies. Individual factors like resources, costs, and price volatility must be considered. Capital costs regularly exceed estimates. While uncertainty remains, companies can improve valuations through share buybacks or focusing on quality projects rather than assuming commodity demand will always increase.
3Q 06 Earnings Slides
This document contains:
1) A summary of PPG Industries' third quarter 2006 financial results, including details on sales, earnings, and market indicators. Sales increased 10% overall with growth in all business segments. Earnings declined from the prior year.
2) Comments on key topics and outlook for 2006, including the economy, inflation, and volume trends by region and business segment.
3) An overview of how PPG Industries uses cash, including funding businesses and growth initiatives, paying dividends, and stock repurchases.
3Q 2008 SLIDES
The document summarizes PPG Industries' third quarter 2008 financial results. It reports double-digit sales and earnings growth across many business segments. It also notes strong cash generation that has allowed over $650 million in debt reduction so far in 2008. Challenges in some segments like industrial coatings and automotive are also highlighted due to economic slowdowns. Overall, the company reports continued strong financial performance despite difficult market conditions in some areas.
Electrolux Presentation SEB Enskilda Capital Goods Seminar 2011
This document discusses Electrolux's priorities for creating shareholder value. It outlines Electrolux's historical performance on metrics like return on invested capital, capital turnover, return on net assets, and sales growth. It then discusses strategies for accelerating growth, including expanding in emerging markets through acquisitions like CTI in Chile and Argentina and the Olympic Group in Egypt and the Middle East. Both acquisitions provide access to high-growth markets and strengthen Electrolux's positions in Latin America and the MENA region.
Q3 2009 Earning Report of The Mosaic Company
Mosaic reported its 1st quarter fiscal 2010 earnings. Net sales were $1.5 billion, down from $4.3 billion in the prior year. Net earnings were $100.6 million compared to $1.2 billion last year. Mosaic expects global economic recovery to drive increased demand for grains and fertilizers. It is pursuing potash and phosphate expansion projects and maintaining competitive production to position itself for recovery. The presentation reviewed Mosaic's strategic priorities and outlook across its business segments.
Korea 2008
Korea has a population of 49 million people and a GDP of $969.9 billion in 2007. Its economy is transitioning from manufacturing and agriculture to a more service-based economy. The new government is working to make Korea a more attractive place for foreign investment through business-friendly policies like lowering corporate taxes, streamlining regulations, and improving labor relations. It aims to develop new industries in areas like green technology, biotech, nanotech, and robotics through increased R&D funding.
Morgan Stanley Basic Materials Conference
This document provides an overview of 3M's performance in 2005 and outlook for 2006 from the perspective of Pat Campbell, 3M's Senior Vice President and Chief Financial Officer, at the Morgan Stanley 2006 Basic Materials Conference.
Key highlights from 2005 include sales growth of 5.8% to $21.2 billion, EPS growth of 13.6% to $4.26, operating income growth of 9.4% to $5 billion, and economic profit growth of 11.3% to $2 billion. All business segments achieved positive organic local currency sales growth.
For 2006, 3M plans over $10 million in growth investments, primarily aimed at organic growth, and a 15% increase in capital expenditures.
Alkholifey
The document discusses Saudi Arabia's fiscal policy and role in finance and investment. It notes Saudi Arabia's stable political system, predictable economic policies, and well-supervised financial sector provide an attractive business environment. It also discusses Saudi Arabia's systemic role in ensuring global energy market stability and framing sustainable global growth policies. Government spending focuses on infrastructure, human capital, and health. Fiscal policy aims to promote non-oil growth through various financing institutions that support private sector development.
Bayer India- Result Update
Bayer CropScience reported disappointing 1QFY2011 results with 20% revenue growth and an 8% decline in profit. EBITDA margin contracted to 11% from 14% due to a 358 basis point drop in gross margins. While the company is expected to benefit from high commodity prices, its stock price is nearing the analyst's revised target valuation after recent gains. The analyst maintains a Neutral rating.
Earnings Release 4Q08 - Presentation
The document provides an earnings release for Tempo ParticipaçÃμes for 4Q08, highlighting a CEO change, stock buyback programs, and SAP implementation. It also summarizes key financial metrics for the health, dental, and assistance segments, showing overall revenue and EBITDA growth despite quarterly declines in some segments. Total CAPEX for 2008 was R$28.4 million.
Earnings Release 4Q08 - Presentation
The document provides an earnings release for Tempo ParticipaçÃμes for 4Q08, highlighting a CEO change, stock buyback programs, and SAP implementation. It also summarizes key financial metrics for the health, dental, and assistance segments, showing overall revenue and EBITDA growth despite quarterly declines in some segments. Total CAPEX for 2008 was R$28.4 million.
Tempo%20 Participa%E7%F5es%20 %204 T08%20 Apresenta%E7%E3o%20 %20 Eng
The document provides an earnings release for Tempo ParticipaçÃμes for 4Q08, highlighting a CEO change, stock buyback programs, and SAP implementation. It also summarizes key financial metrics for the health, dental, and assistance segments, showing overall revenue and EBITDA growth despite quarterly declines in some segments. Total CAPEX for 2008 was R$30.5 million.
Industry statistics 23092011
The auto component industry in India has grown significantly from 2007 to 2011, with a turnover CAGR of 14.6% and estimated future growth of 11% annually to 2021. Exports have also increased substantially, with an 11% CAGR from 2007 to 2011 and estimated future growth of 18.8% annually. The industry supplies a comprehensive range of components and exports 80% to automakers and tier 1 companies, with the remaining 20% going to the aftermarket. Investments in the industry have also risen, reaching $2.3 billion in 2010-11, with $2.5 billion expected for the next year.
2Q06EarningsSlides
The document discusses PPG Industries' forward-looking statements and provides the following information:
1) PPG's forward-looking statements involve risks and uncertainties that may cause actual results to differ from expectations.
2) Key factors that could affect results include competition, raw material costs, supplier relationships, economic conditions, litigation, and foreign exchange rates.
3) The information in the presentation is current as of July 20, 2006 and any distribution after that date does not confirm or update the information.
CSChemicalConference_2006_Handout
1) Avery Dennison presented preliminary financial results for the first half of 2006, showing earnings per share up 14% due to improved margins.
2) Key priorities include maintaining pricing discipline, achieving $85-100 million in annual savings from restructuring, and accelerating organic sales growth to a target range of 4-6% over the medium term.
3) Emerging markets are seen as a major growth driver, expected to increase their contribution to overall growth and profitability significantly by 2010.
Cadila ru2 qfy2011-191010
Cadila Healthcare reported strong results for the second quarter of fiscal year 2011. Net sales increased 21.2% year-over-year to 1,106 crore, ahead of analyst estimates, driven by growth in the domestic formulation, US, and Brazil businesses. Operating profit margin expanded to 21.2% compared to 18.9% in the prior year quarter, due to a favorable product mix and lower selling, general, and administrative expenses. Net profit grew 29.5% to 171 crore. For fiscal year 2011, the company reiterated its guidance of 27-28% revenue growth to 4,300-4,600 crore and a 100 basis point improvement in operating profit margin.
2011 Westport Annual General Meeting
The global leader in natural gas engines, Westport, held a shareholder meeting on April 12, 2012. The presentation provided an overview of Westport, including its focus on transforming engines from petroleum-fueled to alternative-fueled using its natural gas technology. It also summarized Westport's business structure, products, key partnerships and joint ventures, financial highlights, and investment opportunities as the pure-play global leader in natural gas fuel systems.
In vivo cro market
In vivo CRO Market Size, Share & Trends Analysis Report By Product Type, By GLP Type, By Indication (Diabetes, Obesity, Autoimmune/Inflammatory, CNS Conditions), And Segment Forecasts, 2019 - 2026
LehmanBrothers_2607Handout
The document provides an overview of Lehman Brothers' Industrial Select Conference on February 6, 2007. It includes forward-looking statements and discusses key risks and uncertainties. Dean Scarborough, President and CEO of Avery Dennison, then discusses Avery Dennison's balanced strategy for growth and productivity improvement. Key highlights include modest sales growth, margin expansion, investments in emerging markets and RFID, and 2007 earnings guidance of $4.00-$4.35 per share.
Graphite India
Graphite India reported a 10.2% increase in net sales for the first quarter of fiscal year 2011, which was below expectations. Net profit declined 23.9% from the previous year due to a drop in operating margins from 29.0% to 23.0% as graphite electrode prices fell more than anticipated. Segment sales grew for power, steel, and others but were muted for graphite and carbon. While first quarter results were below forecasts, management expects demand and prices to increase going forward as the global steel industry recovers.
NPK Investment Report - 9.23.10
National Presto Industries operates three business segments: Housewares, Defense Products, and Absorbent Products. The author believes Presto is undergoing an operational restructuring that will lead to higher returns, but the market has not fully appreciated this due to Presto's history, uncertainty around its defense segment, and lack of analyst coverage. Using a sum-of-parts valuation, the author estimates Presto's intrinsic value at $112 per share based on conservative estimates for each segment plus net cash, and would be willing to pay $90 per share, a 20% discount, given applied conservatism. At $105 per share, Presto trades at attractive multiples of cash flow and EBITDA on a consolidated basis.
HCLF 2013: Evidence at the Center of Care
Healthcare Leadership Forum’s Evidence at the Center of Care focused on implementing IT and evidence-based medicine in every day practice. This meeting brought together clinical and IT leaders in an interactive environment where attendees learned about best practices for integrating evidence into clinical practice, enabling more efficient, high-quality healthcare delivery.
Nov. 14-15, 2013 | Chicago
Sponsored by: ClinicalKey / Elsevier
Presented by: Clinical Innovation + Technology
More Related Content
Similar to Forecast of Statin Market to 2018
3Q 06 Earnings Slides
This document contains:
1) A summary of PPG Industries' third quarter 2006 financial results, including details on sales, earnings, and market indicators. Sales increased 10% overall with growth in all business segments. Earnings declined from the prior year.
2) Comments on key topics and outlook for 2006, including the economy, inflation, and volume trends by region and business segment.
3) An overview of how PPG Industries uses cash, including funding businesses and growth initiatives, paying dividends, and stock repurchases.
3Q 2008 SLIDES
The document summarizes PPG Industries' third quarter 2008 financial results. It reports double-digit sales and earnings growth across many business segments. It also notes strong cash generation that has allowed over $650 million in debt reduction so far in 2008. Challenges in some segments like industrial coatings and automotive are also highlighted due to economic slowdowns. Overall, the company reports continued strong financial performance despite difficult market conditions in some areas.
Electrolux Presentation SEB Enskilda Capital Goods Seminar 2011
This document discusses Electrolux's priorities for creating shareholder value. It outlines Electrolux's historical performance on metrics like return on invested capital, capital turnover, return on net assets, and sales growth. It then discusses strategies for accelerating growth, including expanding in emerging markets through acquisitions like CTI in Chile and Argentina and the Olympic Group in Egypt and the Middle East. Both acquisitions provide access to high-growth markets and strengthen Electrolux's positions in Latin America and the MENA region.
Q3 2009 Earning Report of The Mosaic Company
Mosaic reported its 1st quarter fiscal 2010 earnings. Net sales were $1.5 billion, down from $4.3 billion in the prior year. Net earnings were $100.6 million compared to $1.2 billion last year. Mosaic expects global economic recovery to drive increased demand for grains and fertilizers. It is pursuing potash and phosphate expansion projects and maintaining competitive production to position itself for recovery. The presentation reviewed Mosaic's strategic priorities and outlook across its business segments.
Korea 2008
Korea has a population of 49 million people and a GDP of $969.9 billion in 2007. Its economy is transitioning from manufacturing and agriculture to a more service-based economy. The new government is working to make Korea a more attractive place for foreign investment through business-friendly policies like lowering corporate taxes, streamlining regulations, and improving labor relations. It aims to develop new industries in areas like green technology, biotech, nanotech, and robotics through increased R&D funding.
Morgan Stanley Basic Materials Conference
This document provides an overview of 3M's performance in 2005 and outlook for 2006 from the perspective of Pat Campbell, 3M's Senior Vice President and Chief Financial Officer, at the Morgan Stanley 2006 Basic Materials Conference.
Key highlights from 2005 include sales growth of 5.8% to $21.2 billion, EPS growth of 13.6% to $4.26, operating income growth of 9.4% to $5 billion, and economic profit growth of 11.3% to $2 billion. All business segments achieved positive organic local currency sales growth.
For 2006, 3M plans over $10 million in growth investments, primarily aimed at organic growth, and a 15% increase in capital expenditures.
Alkholifey
The document discusses Saudi Arabia's fiscal policy and role in finance and investment. It notes Saudi Arabia's stable political system, predictable economic policies, and well-supervised financial sector provide an attractive business environment. It also discusses Saudi Arabia's systemic role in ensuring global energy market stability and framing sustainable global growth policies. Government spending focuses on infrastructure, human capital, and health. Fiscal policy aims to promote non-oil growth through various financing institutions that support private sector development.
Bayer India- Result Update
Bayer CropScience reported disappointing 1QFY2011 results with 20% revenue growth and an 8% decline in profit. EBITDA margin contracted to 11% from 14% due to a 358 basis point drop in gross margins. While the company is expected to benefit from high commodity prices, its stock price is nearing the analyst's revised target valuation after recent gains. The analyst maintains a Neutral rating.
Earnings Release 4Q08 - Presentation
The document provides an earnings release for Tempo ParticipaçÃμes for 4Q08, highlighting a CEO change, stock buyback programs, and SAP implementation. It also summarizes key financial metrics for the health, dental, and assistance segments, showing overall revenue and EBITDA growth despite quarterly declines in some segments. Total CAPEX for 2008 was R$28.4 million.
Earnings Release 4Q08 - Presentation
The document provides an earnings release for Tempo ParticipaçÃμes for 4Q08, highlighting a CEO change, stock buyback programs, and SAP implementation. It also summarizes key financial metrics for the health, dental, and assistance segments, showing overall revenue and EBITDA growth despite quarterly declines in some segments. Total CAPEX for 2008 was R$28.4 million.
Tempo%20 Participa%E7%F5es%20 %204 T08%20 Apresenta%E7%E3o%20 %20 Eng
The document provides an earnings release for Tempo ParticipaçÃμes for 4Q08, highlighting a CEO change, stock buyback programs, and SAP implementation. It also summarizes key financial metrics for the health, dental, and assistance segments, showing overall revenue and EBITDA growth despite quarterly declines in some segments. Total CAPEX for 2008 was R$30.5 million.
Industry statistics 23092011
The auto component industry in India has grown significantly from 2007 to 2011, with a turnover CAGR of 14.6% and estimated future growth of 11% annually to 2021. Exports have also increased substantially, with an 11% CAGR from 2007 to 2011 and estimated future growth of 18.8% annually. The industry supplies a comprehensive range of components and exports 80% to automakers and tier 1 companies, with the remaining 20% going to the aftermarket. Investments in the industry have also risen, reaching $2.3 billion in 2010-11, with $2.5 billion expected for the next year.
2Q06EarningsSlides
The document discusses PPG Industries' forward-looking statements and provides the following information:
1) PPG's forward-looking statements involve risks and uncertainties that may cause actual results to differ from expectations.
2) Key factors that could affect results include competition, raw material costs, supplier relationships, economic conditions, litigation, and foreign exchange rates.
3) The information in the presentation is current as of July 20, 2006 and any distribution after that date does not confirm or update the information.
CSChemicalConference_2006_Handout
1) Avery Dennison presented preliminary financial results for the first half of 2006, showing earnings per share up 14% due to improved margins.
2) Key priorities include maintaining pricing discipline, achieving $85-100 million in annual savings from restructuring, and accelerating organic sales growth to a target range of 4-6% over the medium term.
3) Emerging markets are seen as a major growth driver, expected to increase their contribution to overall growth and profitability significantly by 2010.
Cadila ru2 qfy2011-191010
Cadila Healthcare reported strong results for the second quarter of fiscal year 2011. Net sales increased 21.2% year-over-year to 1,106 crore, ahead of analyst estimates, driven by growth in the domestic formulation, US, and Brazil businesses. Operating profit margin expanded to 21.2% compared to 18.9% in the prior year quarter, due to a favorable product mix and lower selling, general, and administrative expenses. Net profit grew 29.5% to 171 crore. For fiscal year 2011, the company reiterated its guidance of 27-28% revenue growth to 4,300-4,600 crore and a 100 basis point improvement in operating profit margin.
2011 Westport Annual General Meeting
The global leader in natural gas engines, Westport, held a shareholder meeting on April 12, 2012. The presentation provided an overview of Westport, including its focus on transforming engines from petroleum-fueled to alternative-fueled using its natural gas technology. It also summarized Westport's business structure, products, key partnerships and joint ventures, financial highlights, and investment opportunities as the pure-play global leader in natural gas fuel systems.
In vivo cro market
In vivo CRO Market Size, Share & Trends Analysis Report By Product Type, By GLP Type, By Indication (Diabetes, Obesity, Autoimmune/Inflammatory, CNS Conditions), And Segment Forecasts, 2019 - 2026
LehmanBrothers_2607Handout
The document provides an overview of Lehman Brothers' Industrial Select Conference on February 6, 2007. It includes forward-looking statements and discusses key risks and uncertainties. Dean Scarborough, President and CEO of Avery Dennison, then discusses Avery Dennison's balanced strategy for growth and productivity improvement. Key highlights include modest sales growth, margin expansion, investments in emerging markets and RFID, and 2007 earnings guidance of $4.00-$4.35 per share.
Graphite India
Graphite India reported a 10.2% increase in net sales for the first quarter of fiscal year 2011, which was below expectations. Net profit declined 23.9% from the previous year due to a drop in operating margins from 29.0% to 23.0% as graphite electrode prices fell more than anticipated. Segment sales grew for power, steel, and others but were muted for graphite and carbon. While first quarter results were below forecasts, management expects demand and prices to increase going forward as the global steel industry recovers.
NPK Investment Report - 9.23.10
National Presto Industries operates three business segments: Housewares, Defense Products, and Absorbent Products. The author believes Presto is undergoing an operational restructuring that will lead to higher returns, but the market has not fully appreciated this due to Presto's history, uncertainty around its defense segment, and lack of analyst coverage. Using a sum-of-parts valuation, the author estimates Presto's intrinsic value at $112 per share based on conservative estimates for each segment plus net cash, and would be willing to pay $90 per share, a 20% discount, given applied conservatism. At $105 per share, Presto trades at attractive multiples of cash flow and EBITDA on a consolidated basis.
Similar to Forecast of Statin Market to 2018 (20)
Electrolux Presentation SEB Enskilda Capital Goods Seminar 2011
Electrolux Presentation SEB Enskilda Capital Goods Seminar 2011
Tempo%20 Participa%E7%F5es%20 %204 T08%20 Apresenta%E7%E3o%20 %20 Eng
Tempo%20 Participa%E7%F5es%20 %204 T08%20 Apresenta%E7%E3o%20 %20 Eng
More from TriMed Media Group
HCLF 2013: Evidence at the Center of Care
Healthcare Leadership Forum’s Evidence at the Center of Care focused on implementing IT and evidence-based medicine in every day practice. This meeting brought together clinical and IT leaders in an interactive environment where attendees learned about best practices for integrating evidence into clinical practice, enabling more efficient, high-quality healthcare delivery.
Nov. 14-15, 2013 | Chicago
Sponsored by: ClinicalKey / Elsevier
Presented by: Clinical Innovation + Technology
2012 CMIO Leadership Forum
Highlights from the 2012 CMIO Leadership Forum: Transforming Healthcare through Evidence-Based Medicine
UPenn Oregon Telestroke
Telemedicine expanded access to stroke care in Oregon. A survey found 43% of respondents had access to in-person stroke care, 76% to telemedicine care, and 40% to both. Counties with high telemedicine access had lower uninsured rates and older adult populations compared to counties with low access. Telemedicine reduced the population without access to stroke care from 57% to 20%.
PCPs speak out on rad reporting
As radiologists strive to improve reporting and service to referring physicians, the input of providers can help inform process improvement.
Step up to bat and practice dictating complex cases a residents guide to effe...
Findings:
There is a normal appendix
visualized in the RLQ. The
small bowel appears normal
without evidence of
diverticulum.
The document provides guidelines for effective radiology reporting, noting that residency training focuses
Impression:
little on dictation skills. It highlights the importance of concise, clinically relevant reports that answer the
No evidence of Meckel
diverticulum. Normal exam.
clinical question. The guidelines emphasize organizing findings logically, providing a clear impression, and
focusing reports on the clinical history and diagnosis rather than just describing images.
Radiology Workflow: Recognizing Clinical & Financial Benefits of Implementing...
This document summarizes a presentation about implementing an integrated radiology information system (RIS), picture archiving and communication system (PACS), and reporting solution at Rutland Regional Medical Center. The system provides streamlined workflow from patient check-in through report delivery. It has led to improved efficiency through a unified system, faster report turnaround times, reduced transcription needs, better monitoring of metrics, and enhanced collaboration between radiologists and other physicians. The integrated system also allows for improved coding and billing processes as well as cost savings through staffing reductions.
RSNA 2012 - Photolog
One last look at RSNA 2012. A photo log from the conference. Provided by Health Imaging - http://www.healthimaging.com
201209 cit-w&inicu
James F. Padbury, MD and Betty R. Vohr, MD give a tour of the neonatal intensive care unit (NICU) at Women & Infants Hospital of Rhode Island. The NICU has multiple family rooms where loved ones can visit patients and staff host family events. All clinical staff carry mobile devices to communicate and receive alerts about patients. Families send thank you cards expressing gratitude to the nurses. The NICU was designed architecturally to feel like one connected space across two floors. High-definition imaging stations are available for doctors to view diagnostic images. Private patient rooms are identical to make navigation easier for staff.
Inside a Private HIE: Clinical, Economic and Operational Successes at The Was...
The Washington Health Information Network (WHIN) is a private health information exchange (HIE) that connects The Washington Hospital and physician practices affiliated with the Washington Physician Hospital Organization (WPHO). MobileMD is the backbone of WHIN. Denise Abraham, the health information exchange coordinator for The Washington Hospital, and Charles R. Vargo, executive director of the WPHO, work closely to keep this vital piece of caregiver connectivity alive. WHIN is having a positive impact on patient care and clinical practice by increasing physician knowledge and boosting efficiency by allowing physicians, nursing and key clinical staff secure access to key information such as lab and radiology reports and EKGs. The private HIE has united 13 EMRs from different vendors via interfaces to provide one data repository for enterprise access. Learn why they chose a private HIE, how it has evolved from 2006 until now and what advice they offer to other healthcare systems ready to embark on a private HIE project.
How Healthcare Reform Is Affecting Radiology, Pam Kassing
How Healthcare Reform Is Affecting Radiology - Presented by: http://www.healthimaging.com - speaker: Pam Kassing, MS, Senior Director of Health Policy, American College of Radiology. Presented at the GE Virtual Conference, September 14, 2011.
Meaningful Use: Impact on Radiology, Arun Krishnaraj
Meaningful Use and Its Impact on Medical Imaging: Part 1 - Presented by http://www.healthimaging.com - invited speaker: Arun Krishnaraj, MD, MPH, Massachusetts General Hospital. Part of the GE Virtual Conference September 14, 2011.
CMIO Summit 2011 | Reid Coleman
The document discusses different approaches to meeting meaningful use (MU) criteria. It identifies some "wrong ways" like "duck and cover", doing the minimum to get through year one ("one and done"), and just focusing on the money ("take the money and run"). The author advocates a better approach of linking the criteria to seven evidence-based quality improvement projects, plus ensuring patient privacy protections and effective training and communication. While certification can be complicated, the author believes their approach can help hospitals actualize improvements in a meaningful way to qualify for MU incentives.
2011 CMIO Summit | Justin Graham
This document summarizes strategies for clinician adoption after an EHR go-live presented by Dr. Justin Graham. It recommends embedding HIT into organizational strategy, evolving governance from projects to operations, having realistic EHR expectations, setting virtuous workflow cycles, preparing for requests, learning informatics team management, and keeping vision and momentum. Culture change takes time and an engaged clinical leader, informatics team, and communication plan are important for adoption.
2011 CMIO Summit | Don Levick
This document discusses clinical decision support (CDS), which uses clinical knowledge and patient data to improve healthcare decisions. It outlines several types of CDS interventions like drug interactions checking and standardized order sets. Successful CDS requires delivering the right information to the right person in the right format through the right channel at the right time. Organizations should use CDS strategically to achieve priorities like reducing medical errors. The document provides recommendations for implementing an effective CDS program like gaining leadership support, appointing a champion, and continually communicating the program's value.
2011 CMIO Summit | David Cochran
This document provides an overview of health information exchange (HIE) in Vermont. It discusses VITL, a non-profit organization that operates the statewide HIE, connecting hospitals, practices, and other providers. It describes how HIE is integrated into Vermont's health reform efforts like the Blueprint for Health, which uses clinical data to support practices' transformation to the patient-centered medical home model and provide population health management. The document also notes some learnings around vendor challenges, interoperability issues, and ensuring HIE sustainability beyond public funding as payment models evolve.
2011 CMIO Summit | Brian McDonough
This document discusses communication strategies for an electronic health record implementation project. It emphasizes the importance of communicating clearly and honestly with all stakeholders, including physicians, nurses, and other staff. Effective communication requires understanding different audiences, crafting individualized messages, and selecting the right messengers who are respected within each group. The overall goal of communication is to help stakeholders understand and buy into the changes required to achieve the project's objectives.
2011 CMIO Summit | Ben Stein
The document outlines an agenda for a CMIO Summit on June 10th, 2011. The agenda includes definitions, an overview of LIPIX including its funding and mission, explanations of health information exchange and RHIO, LIPIX's goals, participating providers, technical architecture, use cases, products/services, and strategies for engaging providers. It aims to educate on LIPIX's role in facilitating health information exchange across the region and debunk common myths about HIE.
2011 CMIO Summit | Abha Agrawal
This document discusses collaboration strategies between the Chief Medical Information Officer (CMIO) and Chief Medical Officer (CMO) at Kings County Hospital. It provides background on Kings County Hospital, which is a 650-bed academic and tertiary hospital within the New York City Health & Hospitals Corporation public hospital system. It then outlines how the CMIO and CMO roles have evolved to focus more on analytics, reporting, and using health IT to improve quality, safety, and achieve regulatory and reform goals like accountable care. Specific examples of collaborations around computerized physician order entry, clinical decision support, and reducing hospital-acquired infections are also provided.
CMIO Summit 2011 | Karen Bell
CCHIT provides EHR certification programs including an ONC-ATCB program and their own CCHIT Certified program. They also offer an EHR Alternative Certification for Healthcare Providers (EACH) program to help providers of self-developed or customized EHRs achieve certification. The presentation covered the certification landscape, certification processes, tips for providers, and the future of EHR certification.
More from TriMed Media Group (20)
Step up to bat and practice dictating complex cases a residents guide to effe...
Step up to bat and practice dictating complex cases a residents guide to effe...
Radiology Workflow: Recognizing Clinical & Financial Benefits of Implementing...
Radiology Workflow: Recognizing Clinical & Financial Benefits of Implementing...
Inside a Private HIE: Clinical, Economic and Operational Successes at The Was...
Inside a Private HIE: Clinical, Economic and Operational Successes at The Was...
How Healthcare Reform Is Affecting Radiology, Pam Kassing
How Healthcare Reform Is Affecting Radiology, Pam Kassing
Meaningful Use: Impact on Radiology, Arun Krishnaraj
Meaningful Use: Impact on Radiology, Arun Krishnaraj
Recently uploaded
Know the difference between Endodontics and Orthodontics.
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
The Nervous and Chemical Regulation of Respiration
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
What is Obesity? How to overcome Obesity?
Obesity is a chronic complex disease defined by excessive fat deposits that can impair health.
Acute Gout Care & Urate Lowering Therapy .pdf
In this document , the management of acute gout attacks and a description of urate lowering therapy is mentioned.
Histololgy of Female Reproductive System.pptx
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
How to Control Your Asthma Tips by gokuldas hospital.
Respiratory issues like asthma are the most sensitive issue that is affecting millions worldwide. It hampers the daily activities leaving the body tired and breathless.
The key to a good grip on asthma is proper knowledge and management strategies. Understanding the patient-specific symptoms and carving out an effective treatment likewise is the best way to keep asthma under control.
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
cosmetics and cosmeceuticals
Muskan
mpharm
2nd semester
Guru Gobind Singh college of pharmacy, yamunanagar, haryana
Pharmacology of 5-hydroxytryptamine and Antagonist
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Top Travel Vaccinations in Manchester
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
Ageing, the Elderly, Gerontology and Public Health
Challenges associated with ageing from a public health perspective
biomechanics of running. Dr.dhwani.pptx
The biomechanics of running involves the study of the mechanical principles underlying running movements. It includes the analysis of the running gait cycle, which consists of the stance phase (foot contact to push-off) and the swing phase (foot lift-off to next contact). Key aspects include kinematics (joint angles and movements, stride length and frequency) and kinetics (forces involved in running, including ground reaction and muscle forces). Understanding these factors helps in improving running performance, optimizing technique, and preventing injuries.
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...ayushrajshrivastava7
Regulatory Affairs
Full hand written notes
M.pharm - 1st year .Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...Université de Montréal
“Psychiatry and the Humanities”: An Innovative Course at the University of Montreal Expanding the medical model to embrace the humanities. Link: https://www.psychiatrictimes.com/view/-psychiatry-and-the-humanities-an-innovative-course-at-the-university-of-montrealRecently uploaded (20)
Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
Forecast of Statin Market to 2018
- 1. Forecast of Statin Market to 2018 A GBI Research analysis of the statin market projects that the generic market is expected to grow significantly, which in turn will lead to a drop in revenues.
- 2. Global Statin Market The decline in the global statin market is expected to accelerate into 2018. 25 (2.5%) Series1, 2011, 20.5 20 Revenue ($bn) (7.2%) 15 Series1, 2018, 12.2 10 5 0 2004 2011 2018 Source: GBI Research
- 3. U.S. Statin Market The U.S. statin market peaked in 2006 with revenues of $12.3 billion but with the loss of patents for Zocor in 2006 and Lipitor in 2011, revenues are likely to plunge. 14 12 (1%) 10 Revenue ($bn) (8.4%) 8 6 4 2 0 2004 2011 2018 Source: GBI Research
- 4. Global Statin Market, 2004-2018 30 The highly competitive market, growing use of generics and limited new therapies in development likely will dampen interest in entering the market. 25 CAGR (2004–2011) : -2.5% CAGR (2011–2018) : -7.2% 20 CAGR = Compound Annual Growth Rate Revenue ($bn) 15 10 5 0 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 Source: GBI Research